Cancer News and Research

Latest Cancer News and Research

New research may lead to treatments for atherosclerosis

Scientists are one step closer to deciphering the molecular signaling process controlling innate immunity with the discovery that a molecule called IRAK1 regulates the expression of the anti-inflammatory cytokine IL-10. Because atherosclerosis patients often have elevated IL-10 levels, IRAK1 may be a viable target for developing therapeutics for atherosclerosis.

29 Nov 2004

New computer-aided diagnosis (CAD) methods for cancer

Not all masses are cancer. When a person undergoes a scan to identify a lump or nodule, the radiologist looks at the texture, the borders and the shape to determine if it is malignant or just a benign growth.

29 Nov 2004

Cancer survival rates differ among ethnic groups in New Zealand

There were 115,811 adult patients with an invasive cancer recorded on the New Zealand Cancer Registry between 1994 and 2002. The study linked these patients to the Mortality Collection in order to calculate survival rates. Ethnicity (Maori, Pacific, and non-Maori/non-Pacific) was assigned from hospitalisation and health administration databases.

24 Nov 2004

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.

24 Nov 2004

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.

24 Nov 2004

Study links a novel protein pathway to the aggressive progression of breast cancer

Cytogen Corporation today announced the publication of a study linking a novel protein pathway to the aggressive progression of breast cancer.

24 Nov 2004

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales. Smoking and drinking cause most cancers of the mouth, lip and tongue (oral cavity), throat and voice box.

24 Nov 2004

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Together with an international research team, researchers from VTT Technical Research Centre of Finland have developed an effective method for the screening and identification of genes that under normal conditions suppress cancer growth.

24 Nov 2004

Genetic defect boosts the chances of becoming addicted to tobacco

A genetic defect, which slows the liver's capacity to clear nicotine from the body, boosts the chances of becoming addicted to tobacco, finds research in Tobacco Control. The effects are particularly strong in new, young smokers, the study shows.

24 Nov 2004

Smoking killed almost 5 million people around the world in 2000

Smoking killed almost 5 million people around the world in 2000, reveals research in Tobacco Control. Over half the deaths were in smokers aged 30 to 69.

24 Nov 2004

Researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer

A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.

23 Nov 2004

New mechanism that contributes to the development of some breast and ovarian cancers

Researchers at Mount Sinai School of Medicine have discovered a new mechanism of activation of a pathway known to be implicated in many cancers.

23 Nov 2004

Breast conserving therapy safe for hereditary breast cancer

Women with hereditary breast cancer treated with breast conserving therapy appear to have no increased risk for recurrence in the treated breast, according to results from a prospective study published in the January 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

23 Nov 2004

Early results shed light on lung cancer screening advance

One in three smokers or former smokers screened for lung cancer at a baseline and one year follow-up visit using a recent advance in computed tomography tested positive according to a new study. Of those, 12 percent had lung biopsies, and 7 percent were diagnosed with lung cancer.

23 Nov 2004

Stem cells' repair skills could be link to cancer

Johns Hopkins researchers say there is growing evidence that stem cells gone awry in their efforts to repair tissue damage could help explain why long-term irritation, such as from alcohol or heartburn, can create a breeding ground for certain cancers.

23 Nov 2004

Highly obese women are 12 times more likely to have diabetes

Highly obese women are 12 times more likely to have diabetes or knee replacement surgery, and five times more likely to have high blood pressure than women who are at a normal weight, says a new study.

23 Nov 2004

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Nov 2004

Low-dose antioxidant supplementation may reduce the risk of cancer among men, but not in women

According to the article, antioxidants including beta carotene, ascorbic acid, vitamin E, selenium, and zinc may prevent some of the harmful effects caused by free radicals – reactive molecules produced by metabolism in the body.

23 Nov 2004

Covering up reduces exposure to cancer-causing ultraviolet radiation, according to a systematic review of evidence

Educating children in primary school and adults at the beach about the benefits of wearing sun-protective hats and clothing can effectively motivate them to cover up and reduce their exposure to cancer-causing ultraviolet radiation, according to a systematic review of evidence.

23 Nov 2004

FDA approves Tarceva (erlotinib)

OSI Pharmaceuticals and Genentech have announced that the U.S. Food and Drug Administration (FDA) has approved, after priority review, Tarceva (erlotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.

20 Nov 2004

Cancer News and Research

Latest Cancer News and Research

New research may lead to treatments for atherosclerosis

New computer-aided diagnosis (CAD) methods for cancer

Cancer survival rates differ among ethnic groups in New Zealand

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Study links a novel protein pathway to the aggressive progression of breast cancer

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Genetic defect boosts the chances of becoming addicted to tobacco

Smoking killed almost 5 million people around the world in 2000

Researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer

New mechanism that contributes to the development of some breast and ovarian cancers

Breast conserving therapy safe for hereditary breast cancer

Early results shed light on lung cancer screening advance

Stem cells' repair skills could be link to cancer

Highly obese women are 12 times more likely to have diabetes

Long-term use of opioid prescriptions by veterans

Low-dose antioxidant supplementation may reduce the risk of cancer among men, but not in women

Covering up reduces exposure to cancer-causing ultraviolet radiation, according to a systematic review of evidence

FDA approves Tarceva (erlotinib)

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in